Tandlægeholdingselskabet Mikkel Wessel ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  10.1% 12.8% 4.8% 6.3% 7.3%  
Credit score (0-100)  25 18 43 37 32  
Credit rating  BB BB BBB BBB BBB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -115 -143 -131 -123 -116  
EBITDA  -949 -943 -911 -968 -1,005  
EBIT  -981 -975 -917 -1,076 -1,114  
Pre-tax profit (PTP)  -52.7 46.7 165.5 -37.1 42.4  
Net earnings  -41.3 36.3 128.7 -29.6 32.2  
Pre-tax profit without non-rec. items  -52.7 46.7 165 -37.1 42.4  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  66.7 34.7 535 426 318  
Shareholders equity total  130 166 295 265 297  
Interest-bearing liabilities  151 0.0 435 375 295  
Balance sheet total (assets)  366 502 1,002 721 737  

Net Debt  151 -259 341 310 234  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -115 -143 -131 -123 -116  
Gross profit growth  17.3% -24.7% 8.5% 6.3% 5.7%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  366 502 1,002 721 737  
Balance sheet change%  48.6% 37.3% 99.6% -28.0% 2.2%  
Added value  -949.2 -942.5 -910.6 -1,070.2 -1,005.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -64 -64 494 -218 -218  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -3.0 -4.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  852.8% 679.3% 698.7% 875.4% 961.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -16.9% 11.0% 22.2% -0.0% 8.4%  
ROI %  -22.8% 21.4% 37.3% -0.1% 9.9%  
ROE %  -27.4% 24.6% 55.8% -10.6% 11.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  35.5% 33.1% 29.4% 36.8% 40.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -15.9% 27.5% -37.5% -32.1% -23.3%  
Gearing %  115.9% 0.0% 147.7% 141.3% 99.3%  
Net interest  0 0 0 0 0  
Financing costs %  1.4% 1.6% 0.8% 9.1% 5.5%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.3 1.4 0.7 0.6 1.0  
Current Ratio  1.3 1.4 0.7 0.6 1.0  
Cash and cash equivalent  0.0 259.0 94.4 64.4 61.1  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  63.2 131.5 -240.4 -161.2 -20.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -949 -943 -911 -1,070 -1,005  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -949 -943 -911 -968 -1,005  
EBIT / employee  -981 -975 -917 -1,076 -1,114  
Net earnings / employee  -41 36 129 -30 32